Concepedia

Melanie C. Smitt

MC

Statistics

Publications

30

Citations

5.6K

H-Index

20

Active since

1993

Affiliations

Stanford University(Current)

Stanford Medicine

Roche (Switzerland)

Dana-Farber Cancer Institute

Yale Cancer Center

Melanie C. Smitt is an author at Stanford University specializing in medicine, breast cancer, and oncology.

Top concepts

Publications per year

1993–2021

30

Publications

30

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

Gϋnter von Minckwitz, Chiun‐Sheng Huang, Max S. Mano et al. · New England Journal of Medicine · 2018 · 2.5K citations · Full text

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial

Ian E. Krop, Sung‐Bae Kim, Antonio González-Martı́n et al. · The Lancet Oncology · 2014 · 705 citations

, , +5

Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial

Ian E. Krop, Sung‐Bae Kim, Antonio González-Martı́n et al. · The Lancet Oncology · 2017 · 504 citations

, , +6

The importance of the lumpectomy surgical margin status in long term results of breast conservation

Melanie C. Smitt, Kent W. Nowels, Mark J. Zdeblick et al. · Cancer · 1995 · 405 citations

A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma

Patrick Y. Wen, David Schiff, Timothy F. Cloughesy et al. · Neuro-Oncology · 2011 · 166 citations · Full text

1–5 of 30